Citation only
via OpenAlex
Aberrant DNA methylation status of endometriosis: Epigenetics as the pathogenesis, biomarker and therapeutic target
Kaei Nasu, Yukie Kawano, Yoshiyuki Tsukamoto, Masayuki Takano, Noriyuki Takai, Haili Li, Yuichi Furukawa, Wakana Abe, Masatsugu Moriyama, Hisashi Narahara
Journal of obstetrics and gynaecology research · 2011 · ▲ 88 citations
Abstract
Endometriosis, a common, benign, estrogen-dependent disease affecting 3-10% of women of reproductive age, is characterized by the ectopic growth of endometrial tissue that is found primarily in the peritoneum, ovaries and rectovaginal septum. Recently, endometriosis has been alternatively described as an immune disease, a genetic disease and a disease caused by exposure to environmental factors, in addition to its usual description as a hormonal disease. In addition, accumulating evidence suggests that various epigenetic aberrations play definite roles in the pathogenesis of endometriosis. Epigenetic alterations reported to date in endometriosis include the genomic DNA methylation of progesterone receptor-B, E-cadherin, homeobox A10, estrogen receptor-β, steroidogenic factor-1 and aromatase. Aberrant expression of DNA methyltransferases, which attach a methyl group to the 5-carbon position of cytosine bases in the CpG island of the promoter region and silence the corresponding gene expression, has also been demonstrated in endometriosis. This review summarizes the recent studies on the aberrant DNA methylation status and aberrant expression of DNA methyltransferases, which regulate DNA methylation, in endometriosis. We also discuss the recent information on the diagnostic and therapeutic implications of epigenetic alterations occurring in endometriosis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/j.1447-0756.2011.01663.x
- Canonical
- link ↗
- Fetched
- 2026-09-25 MST
Cite this
APA
Nasu, K., Kawano, Y., Tsukamoto, Y., Takano, M., Takai, N., Li, H., Furukawa, Y., Abe, W., Moriyama, M., & Narahara, H. (2011). Aberrant DNA methylation status of endometriosis: Epigenetics as the pathogenesis, biomarker and therapeutic target. <em>Journal of obstetrics and gynaecology research</em>. https://doi.org/10.1111/j.1447-0756.2011.01663.x
Vancouver
Nasu K, Kawano Y, Tsukamoto Y, Takano M, Takai N, Li H, et al. Aberrant DNA methylation status of endometriosis: Epigenetics as the pathogenesis, biomarker and therapeutic target. Journal of obstetrics and gynaecology research. 2011. doi:10.1111/j.1447-0756.2011.01663.x.
BibTeX
@article{kaei2011Aberra,
title = {Aberrant DNA methylation status of endometriosis: Epigenetics as the pathogenesis, biomarker and therapeutic target},
author = {Kaei Nasu and Yukie Kawano and Yoshiyuki Tsukamoto and Masayuki Takano and Noriyuki Takai and Haili Li and Yuichi Furukawa and Wakana Abe and Masatsugu Moriyama and Hisashi Narahara},
journal = {Journal of obstetrics and gynaecology research},
year = {2011},
doi = {10.1111/j.1447-0756.2011.01663.x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Molecular Medicine Reports 2016
Open access · CC-BY
DNA methylation in endometriosis (Review)
Epigenetics 2010
Open access · OA
DNA methylation in endometrial cancer
Frontiers in Molecular Neuroscience 2017
Open access · CC-BY
Implications of DNA Methylation in Parkinson’s Disease
Iranian Journal of Allergy Asthma and Immunology 2019
Open access · CC-BY
Epigenetics and Behçet’s Disease: DNA Methylation Specially Highlighted
Carcinogenesis 1997
Citation only
Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis
Reproduction 2019
Open access · OA